Oral cavity squamous cell carcinoma research hub

Tolerability and efficacy of treating locally advanced Resectable Oral Cancer with neoadjuvant INtratumoral anti-CTLA4 ImmunoTherapy combined with systemic anti-PD-1 (ROCinIT).

This clinical trial looks at a new way to treat mouth cancer before surgery. Doctors are testing whether injecting one immunotherapy drug directly into the tumour, alongside a second drug given through a vein, helps the immune system shrink the cancer safely before an operation takes place.